ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$1.31
-0.04 (-2.96%)
Open$1.41
Previous Close$1.35
Day High$1.41
Day Low$1.31
52W High$17.64
52W Low$1.26
Volume—
Avg Volume317.2K
Market Cap4.71M
P/E Ratio—
EPS$-22.04
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+656.5% upside
Current
$1.31
$1.31
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.69B | 14.22B | 1.01M |
| Net Income | -96,490,755 | -84,026,782 | 237.2K |
| Profit Margin | -14.0% | -13.3% | 23.5% |
| EBITDA | -94,308,502 | -86,688,995 | 375.3K |
| Free Cash Flow | — | — | 127.9K |
| Rev Growth | +3.4% | +3.4% | -4.2% |
| Debt/Equity | — | — | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |